Essay Available:
Pages:
2 pages/≈550 words
Sources:
-1
Style:
APA
Subject:
Health, Medicine, Nursing
Type:
Essay
Language:
English (U.S.)
Document:
MS Word
Date:
Total cost:
$ 8.64
Topic:
Semaglutide for Weight Loss
Essay Instructions:
Prepare as a Word document a BRIEF 1–2-page paper (between 500-800 words not including title & Reference page) of the newly approved drug by the FDA (Semaglutide for Weight Loss). Use APA format (7th edition) with a title page, reference page, and in-text citations. Your intended audience is a New Graduate RN.
a. Commercial and generic name of the drug. FDA approved use(s)
b. Mechanism of action(s), Likely adverse effects, toxicity, safety concerns.
c. How long did this drug take from development to approval? Briefly describe the process. Were there any pauses or hurdles in the clinical trial phase? Why? How did the researchers overcome these issues, if any?
d. What kind of marketing campaign was done for the release of this drug? How much does it cost? Is there a cost difference outside the United States?
e. How do patients report problems with the drug?
f. Summary: Reflect on any part of the approval process that got your attention. Would you want to take this drug yourself? Do you feel the drug is safe?
Essay Sample Content Preview:
Semaglutide (Wegovy) for Weight Loss
Name
Institution
Course
Instructor
Date
Semaglutide (Wegovy) for Weight Loss
Commercial and Generic Name, FDA Approved Uses
Semaglutide, sold under the brand name Wegovy, was recently certified by the Food and Drugs Administration FDA in June 2021 to manage weight in adults. It is prescribed for individuals with a BMI of 30 or more or individuals with a BMI of 27 or more with any one or more of the obesity-related complications, including type 2 diabetes, hypertension, or dyslipidemia. The FDA has also approved its use for children aged 12 years and above, especially when, at their first visit, their BMI is above the 95th percentile for age and sex (Kommu & Whitfield, 2024). Wegovy has been designed based on the injectable medication that should be given to the patient once a week to achieve effective and sustainable weight loss.
Mechanism of Action, Adverse Effects, Toxicity, and Safety Concerns
Semaglutide acts similarly to GLP-1, which is a hormone that is responsible for the management of appetite and food consumption (Kim & Jung, 2021). It binds to GLP-1 receptors in the brain, causing feelings of satiety and suppressing appetite, thus enabling patients to have a low-calorie food intake and consequently lose weight.
As with any other drug, semaglutide also has some uses and side effects that may be associated with it. Some of the side effects that are known are Nausea, Vomiting, Diarrhea, and Constipation. They are mostly gastrointestinal, are easily manageable, and tend to reduce with time. However, more serious risks include pancreatitis, gallbladder disease, and possibly soaring heart rate. Ingestion of larger doses of semaglutide for oral or subcutaneously results in serious side effects that include nausea, vomiting, and hypoglycemia (Kommu & Whitfield, 2024). Some nutritional animal studies showed an elevated risk of thyroid C-cell tumors, but this risk has not been proven in human clinical trials. Nevertheless, the usage of semaglutide is coupled with the risk of thyroid tumors, and therefore, it is contraindicated...
Get the Whole Paper!
Not exactly what you need?
Do you need a custom essay? Order right now: